Andrew Anderson reports on the 2017 AAPS Annual Conference by taking a closer look at his recent byline in Laboratory Equipment. He also introduces Joe DiMartino, ACD/Labs' newly appointed solution manager for Luminata, and previews Joe's recent Q&A with Outsourcing-Pharma.com, which discusses how QbD and impurity control management directly impact process development within pharmaceutical R&D organizations.
Join us next week in beautiful Baveno, Italy, for SMASH 2017. This year’s organizing committee took the light-hearted step of naming each session/workshop after the name of a popular song. Staying with this theme, we are organizing our Software Symposium titled “Stairway to Heaven” on Sunday, Sept. 17th, where we intend to present to you all of the very exciting developments in the world of ACD/Labs.
The fascinating world of metabolite identification is something I’ve been learning a lot about recently. The process of drug discovery to drug development to meeting regulations, and the complicated (often manual) workflow. My informant is colleague, Richard Lee. An easy-going and friendly guy with a vast resource of information ranging from metabolite research to cheesy chick flicks (don’t tell him I shared the latter). Read on to learn more about his research and what we'll be discussing at ASMS 2017 this week!
If you happen to be at Bio-IT World this year, be sure to stop by booth #423 to meet the ACD/Labs team and learn more about our solutions; including our new impurity profile information management solution Luminata. We’ll be busy with a number of activities in addition to networking with our fellow peers. Read on for an overview of what our team has planned for the show and where you can find us.
PITTCON 2017 was a particularly big event for the ACD/Labs team this year because we were focused on the launch of Luminata, our new informatics solution for comprehensive impurity and characterization management. The five days we spent in Chicago were the culmination of months of hard work across the entire organization, and I’m pleased to say that the launch went off without a hitch. I had the opportunity to meet with the folks at LabTube to talk about ACD/Labs and our vision for Luminata. Watch the video in our post.
Back in 1996, I recall someone saying that prediction software such as ACD/Labs NMR Predictors would eliminate the need to run lab experiments, which would be replaced with “paper chemistry”. Organic chemistry researchers were even more cynical because they believed that nomenclature software - like ACD/Name - would enable students to avoid learning nomenclature rules. Overall, the faculty were concerned that ACD/NMR Predictors and ACD/Name put their jobs at risk. Fast-forward 21 years later, and I find myself a part of the ACD/Labs team that makes all these wonderful things possible.
PANIC 2017 took place at the Sonesta Resort in Hilton Head Island, SC, a few weeks ago. We knew we were in for a treat when we landed in bright sunshine at Savannah airport—quite a contrast from the cold and snow of Toronto. We realized things were a little bit …different in Hilton Head Island when the shuttle driver told us that yes, there are alligators here and we should be a bit careful when walking next to standing water. In fact we saw a couple of them next to the water in ponds on the way to the venue.
Another PITTCON is upon us and we are eager to get the show started! We will be exhibiting at booth #2918, showcasing our solutions and networking with fellow scientists. Additionally, we will be busy with a number of other activities as well as making an exciting announcement about our product pipeline for 2017. Read more about our team’s activities at PITTCON 2017.
In an effort to help separations scientists succeed in 2017, we decided to launch a webinar series aimed at informing the scientific community about how software can assist and improve method development strategies. Hosted by members of the ACD/Labs’ technical and scientific services team—Anne Marie Smith, Brent G. Pautler, and Karim Kassam—the webinar series consists of three 30-minute sessions on a variety of topics relating to method development.
We’ve been doing a lot of thinking about the value of Computer Assisted Structure Elucidation (CASE) around here lately. There’s a good reason for that: we’ve been doing a lot of work on CASE for the last 18 years, and the work is only accelerating. So it’s worthwhile to reassess every now and then. Much goes into improving software like this to take on ever-more complex tasks, and to do those tasks ever more effectively.